title: Evaluation of the Edwards SAPIEN 3 Transcatheter Valve For Aortic Stenosis.
abstract: Transcatheter aortic valve replacement is a viable alternative to surgical aortic valve replacement in patients with severe aortic stenosis. The SAPIEN 3 is the latest generation of balloon-expandable transcatheter heart valve, designed to address some of the shortcomings of earlier versions of transcatheter heart valves. It has a lower device profile to reduce access-related vascular injury, an improved delivery catheter to facilitate accurate implantation, and incorporates an additional outer sealing cuff to minimize paravalvular leakage. The latest European and North American trials using SAPIEN 3 have documented very low rates of vascular complications and paravalvular regurgitation with rates of stroke and mortality rates lower than anticipated with SAVR in both intermediate and high surgical risk patients.
authors.affiliation: a The Center for Heart Valve Innovation, St Paul's Hospital , Vancouver , Canada.
authors.forename: Nay M
authors.initials: NM
authors.lastname: Htun
authors.affiliation: a The Center for Heart Valve Innovation, St Paul's Hospital , Vancouver , Canada.
authors.forename: John G
authors.initials: JG
authors.lastname: Webb
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000601:surgery*; D002986:Clinical Trials as Topic; D006350:Heart Valve Prosthesis; D006801:Humans; D011358:Product Surveillance, Postmarketing; D065467:Transcatheter Aortic Valve Replacement
keywords: Aortic stenosis; Balloon-expandable aortic valve prosthesis; Edwards SAPIEN 3; Transcatheter aortic valve replacement; Transcatheter heart valve